Propranolol therapy for infantile hemangioma is less toxic but longer in duration than corticosteroid therapy.
作者： Kathryn Sawa , Arjang Yazdani , Michael J Rieder , Guido Filler
DOI: 10.1177/229255031402200409
关键词:
摘要: Department of Pathology and Laboratory Medicine, Western University, London, OntarioCorrespondence: Dr Guido Filler, Paediatrics, Children’s Hospital, London Health Sciences Centre, 339 Windermere Road, Ontario N6G 2V4. Telephone 519-685-8377, e-mail guido.filler@lhsc.on.ca
pulsus.com 参考文章(16)
Steven J. Fishman, John B. Mulliken, Hemangiomas and Vascular Malformations of Infancy and Childhood Pediatric Clinics of North America. ,vol. 40, pp. 1177- 1200 ,(1993) , 10.1016/S0031-3955(16)38656-4
Vishal K Sharma, Frankie OG Fraulin, Danielle O Dumestre, Lori Walker, A Robertson Harrop, Beta-blockers for the treatment of problematic hemangiomas Canadian Journal of Plastic Surgery. ,vol. 21, pp. 23- 28 ,(2013) , 10.1177/229255031302100103
B Thedenat, C Leaute-Labreze, F Boralevi, S Roul, L Labbe, V Marliere, None, Surveillance tensionnelle des nourrissons traités par corticothérapie générale pour un hémangiome Annales De Dermatologie Et De Venereologie. ,vol. 129, pp. 183- 185 ,(2002)
Laurence M. Boon, Dorothy M. MacDonald, John B. Mulliken, Complications of Systemic Corticosteroid Therapy for Problematic Hemangioma Plastic and Reconstructive Surgery. ,vol. 104, pp. 1616- 1623 ,(1999) , 10.1097/00006534-199911000-00002
Qurratulain Hasan, Swee T. Tan, Jason Gush, Sue G. Peters, Paul F. Davis, Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics. ,vol. 105, pp. 117- 120 ,(2000) , 10.1542/PEDS.105.1.117
Michelle L. Bennett, Alan B. Fleischer, Jr, Sarah L. Chamlin, Ilona J. Frieden, Oral Corticosteroid Use Is Effective for Cutaneous Hemangiomas: An Evidence-Based Evaluation Archives of Dermatology. ,vol. 137, pp. 1208- 1213 ,(2001) , 10.1001/ARCHDERM.137.9.1208
Mary B. Leonard, Harold I. Feldman, Justine Shults, Babette S. Zemel, Bethany J. Foster, Virginia A. Stallings, Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. The New England Journal of Medicine. ,vol. 351, pp. 868- 875 ,(2004) , 10.1056/NEJMOA040367
V. Sans, E. D. de la Roque, J. Berge, N. Grenier, F. Boralevi, J. Mazereeuw-Hautier, D. Lipsker, E. Dupuis, K. Ezzedine, P. Vergnes, A. Taieb, C. Leaute-Labreze, Propranolol for Severe Infantile Hemangiomas: Follow-Up Report Pediatrics. ,vol. 124, ,(2009) , 10.1542/PEDS.2008-3458
Ilona J. Frieden, Anita N. Haggstrom, Beth A. Drolet, Anthony J. Mancini, Sheila Fallon Friedlander, Laurence Boon, Sarah L. Chamlin, Eulalia Baselga, Maria C. Garzon, Amy J. Nopper, Dawn H. Siegel, Erin W. Mathes, Deborah S. Goddard, Joyce Bischoff, Paula E. North, Nancy B. Esterly, Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile Hemangiomas Pediatric Dermatology. ,vol. 22, pp. 383- 406 ,(2005) , 10.1111/J.1525-1470.2005.00102.X
Sanjay R. Parikh, David H. Darrow, J. Fredrik Grimmer, Scott C. Manning, Gresham T. Richter, Jonathan A. Perkins, Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns. Archives of Otolaryngology-head & Neck Surgery. ,vol. 139, pp. 153- 156 ,(2013) , 10.1001/JAMAOTO.2013.1218